Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
4 drugs for “NASH”
Approved 2
- Obeticholic acidINTERCEPT PHARMACEUTICALS, INC.Non Alcoholic Steatohepatitis (NASH)
- ResmetiromMADRIGAL PHARMACEUTICALS, INC.NASH
Phase 3 2
- EfruxiferminAkero Therapeutics, Inc.NASH - Nonalcoholic Steatohepatitis; NASH With Fibrosis
- MGL-3196MADRIGAL PHARMACEUTICALS, INC.NASH - Nonalcoholic Steatohepatitis
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.